Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/133117
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | The cystic fibrosis gut as a potential source of multidrug resistant pathogens |
Author: | Taylor, S.L. Leong, L.E.X. Sims, S.K. Keating, R.L. Papanicolas, L.E. Richard, A. Mobegi, F.M. Wesselingh, S. Burr, L.D. Rogers, G.B. |
Citation: | Journal of Cystic Fibrosis, 2020; 20(3):413-420 |
Publisher: | Elsevier BV |
Issue Date: | 2020 |
ISSN: | 1569-1993 1873-5010 |
Statement of Responsibility: | Steven L. Taylor, Lex E.X. Leong, Sarah K. Sims, Rebecca L. Keating, Lito E. Papanicolas, Alyson Richard, Fredrick M. Mobegi, Steve Wesselingh, Lucy D. Burr, Geraint B. Rogers |
Abstract: | Background: The emergence of multidrug resistant (MDR) pathogens represents a profound threat to global health. Individuals with CF have amongst the highest cumulative antibiotic exposure of any pa- tient group, including to critically-important last-line agents. While there is little evidence that antibiotic resistance in airway pathogens results in worse clinical outcomes for CF patients, the potential emergence of MDR pathogens in non-respiratory systems, as a consequence of CF care, represents a potential health threat to the wider population, including family and carers. Methods: Stool from 19 adults with CF and 16 healthy adult controls was subjected to metagenomic sequencing, to assess faecal resistome, and culture-based analysis. Resistant isolates were identified phe- notypically, and genetic determinants of resistance characterised by whole genome sequencing. Results: CF and control faecal resistomes differed significantly ( P = 0.0 0 03). The proportion of reads that mapped to mobile genetic elements was significantly higher in CF ( P = 0.014) and the composition was significantly different ( P = 0.0 0 01). Notably, CF patients displayed higher carriage of plasmid-mediated aminoglycoside-modifying genes ant (6)-Ib, aac (6 ′ )-Ip, and aph (3 ′ )-IIIa ( P < 0.01). Culture-based analy- sis supported higher aminoglycoside resistance, with a higher proportion of aminoglycoside-resistant, Gram-negative bacteria ( P < 0.0 0 01). Isolated extended spectrum beta lactamase (ESBL)-positive Es- cherichia coli from CF stool exhibited phenotypic resistance to tobramycin and gentamicin. Genomic anal- ysis showed co-localisation of both aminoglycoside resistance and ESBL genes, consistent with MDR emer- gence through horizontal gene transfer. Conclusions: The carriage of potentially transmissible resistance within the adult CF gut microbiome is considerably greater than in healthy individuals and could contribute to the emergence and dissemination of MDR pathogens. |
Keywords: | Anti-bacterial agents; Microbiota; Drug resistance; Resistome; Cystic fibrosis |
Rights: | © 2020 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. |
DOI: | 10.1016/j.jcf.2020.11.009 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/GNT1155179 |
Published version: | http://dx.doi.org/10.1016/j.jcf.2020.11.009 |
Appears in Collections: | Medical Sciences publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.